In the PDGFRA#4 case, MET overexpression was most likely caused by the presence of a PTPRZ1-MET fusion, as PTPRZ1 is among the highest expressed genes in glioma, and the fusion places MET under the control of the PTPRZ1 promoter (Table S1). The gene discussed is PDGFRA; the disease is central nervous system cancer.